# Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia

> **NCT01496963** · — · COMPLETED · sponsor: **Ente Ospedaliero Ospedali Galliera** · enrollment: 1500 (estimated)

## Conditions studied

- Thalassemia Major
- Thalassemia Intermedia
- Pulmonary Arterial Hypertension

## Interventions

- **OTHER:** Physician standard-of-care according to ESC/ERS Guidelines

## Key facts

- **NCT ID:** NCT01496963
- **Lead sponsor:** Ente Ospedaliero Ospedali Galliera
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2022-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01496963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01496963, "Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01496963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*